Materiovigilance in hospitals: the role of the biomedical engineer and the local vigilance officer

In hospitals, medical device safety does not stop at purchase. The biomedical engineer and the local materiovigilance officer (CLMV) are on the front line when it comes to reacting to recalls, field safety corrective actions (FSCAs) and ANSM alerts. Here is their role, their obligations, and how never to miss a critical alert on the operated fleet.

The healthcare facility: an actor in materiovigilance

Medical device regulation is often associated with manufacturers. But the operator — the healthcare facility that uses the devices — also has obligations, framed by the French Public Health Code (Articles R.5212-1 et seq.).

Concretely, the facility must:

• Appoint a local materiovigilance officer (CLMV), often the biomedical engineer or the pharmacist
• Report serious incidents or risks of serious incidents to ANSM without delay
• Implement the measures requested by manufacturers and ANSM (recalls, FSCAs)
• Ensure traceability of devices and vigilance actions

The key role of the biomedical engineer

The biomedical engineer manages a fleet that may count thousands of devices — from syringe pumps to MRI scanners. On the vigilance side, their missions include:

• Receiving and triaging safety alerts (FSCA, FSN) issued by manufacturers and relayed by ANSM
• Identifying whether an affected device is actually present in the facility's fleet
• Quarantining or applying the prescribed course of action
• Circulating the information to the user departments concerned
• Tracing the course of action in the materiovigilance file

The challenge: not missing an alert on the fleet

The critical point is filtering. ANSM and manufacturers publish a continuous flow of FSCAs and recalls. Most do not concern your fleet — but the one that does must be handled immediately, because patient safety is at stake.

Yet the follow-up is often done manually: checking the ANSM website, scattered emails, DGS-Urgent subscriptions. The risk of missing one, or of handling it late, is real — and the facility's liability is engaged.

FSCA: the typical course of action

When a field safety corrective action concerns a device in your fleet:

1. Check the inventory (CMMS) to see whether the affected model and lots are present
2. Isolate the affected devices (quarantine) if the FSCA requires it
3. Apply the manufacturer's measure: software update, exchange, modification, withdrawal
4. Inform the user departments and, where applicable, the patients
5. Trace everything in the facility's materiovigilance file
6. Report to ANSM any associated serious incident

Monitoring designed for hospital operations

Most regulatory monitoring tools are designed for manufacturers. The biomedical engineer has a different need: a feed oriented towards recalls, FSCAs and materiovigilance, with a hospital-side course of action — not a manufacturer compliance argument.

MedQara monitors official sources including ANSM, ranks each alert by criticality, and — for biomedical profiles — proposes operations-oriented actions: fleet check, quarantine, traceability. The built-in AI assistant answers questions on the course of action and materiovigilance procedures.

Create your account and configure monitoring tailored to your facility.

This article is provided for informational purposes. For any decision on a device in service, follow the instructions of the manufacturer and of your biomedical department.